Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)

China · Delayed Price · Currency is CNY

15.37

+0.36 (2.40%)

Nov 5, 2026, 3:04 PM CST

Market Cap	3.51B -35.9%
Revenue (ttm)	1.46B -1.0%
Net Income	153.27M -5.7%
EPS	0.67 -6.3%
Shares Out	228.22M
PE Ratio	23.07
Forward PE	n/a
Dividend	0.42 (2.71%)
Ex-Dividend Date	May 29, 2026

Volume	2,680,928
Open	15.39
Previous Close	15.01
Day's Range	14.91 - 15.43
52-Week Range	14.20 - 27.01
Beta	-0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHE:003020

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA. It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlor... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2002

Employees 1,465

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 003020

Full Company Profile

Financial Performance

In 2025, SHE:003020's revenue was 1.55 billion, an increase of 2.33% compared to the previous year's 1.52 billion. Earnings were 165.20 million, an increase of 2.86%.

Financial Statements